CLSI M52 (R2020)

Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, M52Ed1E

Clinical and Laboratory Standards Institute, 08/01/2015

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:01/08/2015

Pages:92

File Size:1 file , 2.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline includes recommendations for verification of commercial US Food and Drug Administration?cleared microbial identification and antimicrobial susceptibility testing systems by clinical laboratory professionals to fulfill regulatory or quality assurance requirements for the use of these systems for diagnostic testing.

More CLSI standard pdf

CLSI M48P

Laboratory Detection and Identification of Mycobacteria; Proposed Guideline, M48-P

$132.00 $265.48

CLSI QMS04-A2

Laboratory Design; Approved Guideline - Second Edition, QMS04A2E

$140.00 $281.60

CLSI I/LA30-P

Immunoassay Interference by Endogenous Antibodies; Proposed Guideline, ILA30PE

$125.00 $250.19

CLSI H20-A2 (R2018)

Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard- Second Edition, H20-A2

$90.00 $180.00